Chemed (NYSE:CHE) EVP Sells 1,000 Shares of Stock

Chemed Corporation (NYSE:CHE) EVP Spencer Lee sold 1,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 11th. The shares were sold at an average price of $547.61, for a total transaction of $547,610.00. Following the transaction, the executive vice president owned 12,931 shares of the company’s stock, valued at approximately $7,081,144.91. This represents a 7.18% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Chemed Trading Down 0.3%

NYSE:CHE traded down $1.40 during trading hours on Friday, hitting $548.80. The stock had a trading volume of 18,182 shares, compared to its average volume of 199,251. The business’s 50 day moving average is $516.47 and its 200-day moving average is $467.03. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.08 and a current ratio of 1.11. The company has a market cap of $7.15 billion, a price-to-earnings ratio of 26.24, a P/E/G ratio of 2.09 and a beta of 0.50. Chemed Corporation has a one year low of $365.20 and a one year high of $562.24.

Chemed (NYSE:CHE) last announced its quarterly earnings results on Tuesday, October 27th. The company reported $6.75 earnings per share for the quarter, topping analysts’ consensus estimates of $6.44 by $0.31. Chemed had a net margin of 10.61% and a return on equity of 35.18%. The company had revenue of $690.94 million for the quarter, compared to analysts’ expectations of $685.04 million. During the same period last year, the firm posted $5.27 earnings per share. The business’s quarterly revenue was up 10.6% compared to the same quarter last year. Sell-side analysts anticipate that Chemed Corporation will post 24.05 EPS for the current fiscal year.

Chemed Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 4th. Shareholders of record on Monday, November 16th will be issued a dividend of $0.70 per share. The ex-dividend date is Monday, November 16th. This represents a $2.80 annualized dividend and a yield of 0.5%. Chemed’s payout ratio is currently 13.40%.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of CHE. Gamco Investors INC. ET AL raised its position in Chemed by 0.9% in the 3rd quarter. Gamco Investors INC. ET AL now owns 20,713 shares of the company’s stock valued at $10,462,000 after buying an additional 185 shares during the last quarter. Advisors Asset Management Inc. bought a new position in shares of Chemed during the 3rd quarter worth approximately $169,434,000. Private Wealth Asset Management LLC acquired a new stake in shares of Chemed in the third quarter valued at approximately $303,000. Private Advisor Group LLC lifted its position in shares of Chemed by 7.7% in the third quarter. Private Advisor Group LLC now owns 1,196 shares of the company’s stock worth $604,000 after purchasing an additional 85 shares in the last quarter. Finally, Focus Advisor Solutions LLC lifted its position in shares of Chemed by 97.1% in the third quarter. Focus Advisor Solutions LLC now owns 4,221 shares of the company’s stock worth $2,132,000 after purchasing an additional 2,079 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on CHE shares. Bank of America reaffirmed a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. Weiss Ratings raised Chemed from a “hold (c)” rating to a “hold (c+)” rating in a research note on Thursday, October 8th. Royal Bank Of Canada raised their target price on shares of Chemed from $548.00 to $585.00 and gave the stock a “sector perform” rating in a report on Thursday, October 29th. UBS Group lifted their price target on shares of Chemed from $650.00 to $675.00 and gave the company a “buy” rating in a research note on Thursday, October 29th. Finally, Jefferies Financial Group upgraded shares of Chemed from a “hold” rating to a “buy” rating and upped their price target for the company from $520.00 to $620.00 in a report on Wednesday, October 28th. Three analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, Chemed currently has an average rating of “Hold” and an average price target of $603.00.

About Chemed

Chemed Corporation is a U.S.-based company operating through two principal businesses: VITAS Healthcare, which provides hospice and palliative care, and Roto-Rooter, which offers plumbing, drain-cleaning and water-restoration services. VITAS serves patients with serious illnesses through home-based care and services in hospice facilities and other care settings. Roto-Rooter serves residential and commercial customers with plumbing and drain services, as well as cleanup and restoration following water damage.